J&J Unit Recalls 44,000 Vials Of Anemia Drug

Law360, New York (August 6, 2008, 12:00 AM EDT) -- Johnson & Johnson subsidiary Ortho Biotech Products LP is voluntarily recalling its blockbuster anemia drug Procrit, after identifying cracks in the necks of a few vials during post-manufacturing inspection.

Even vials with small cracks might not be sterile and shouldn't be injected, the Ortho Biotech said in a statement announcing the recall on Tuesday.

The company is sending out notices to authorized distributors, doctors and patients, in cooperation with the U.S. Food and Drug Administration.

The 44,292 vials, lot number P114942A , were shipped between April...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.